Peter Chua

Peter Chua is a seasoned professional in the field of chemistry with extensive experience in leadership roles across several biotechnology companies. Currently serving as Senior Director of Chemistry at Radionetics Oncology since September 2024, Peter previously held similar senior positions at Erasca, Inc. and Ignyta, Inc., where significant contributions to chemical research and development were made. Earlier career experiences include consulting and division management at The Centre for Drug Research and Development, as well as scientific roles at Cylene Pharmaceuticals, Merck, and Pfizer. Academically, Peter earned a Ph.D. in Synthetic Organic Chemistry from Université de Montréal, completed a Post Doctoral Fellowship at UC Irvine, and holds a B.Sc. in Chemistry and Business Administration from Simon Fraser University.